Blackrock 2037 Municipal Target Term Trust (NYSE:BMN) Shares Up 0.9% – Here’s What Happened
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026
BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency
Blackrock 2037 Municipal Target Term Trust (NYSE:BMN) Short Interest Update
